Evidence map›Paper›PMID 38752889›Full record

ArticleJournal of the American Chemical Society2024

Synthesis of Membrane-Permeable Macrocyclic Peptides via Imidazopyridinium Grafting.

Bo Li, Joshua Parker, Joel Tong, Thomas Kodadek

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Late-Stage Functionalization of Peptides on the Solid Phase.Angewandte Chemie (International ed. in English) · 2026
    Review
  4. Article
  5. In Situ Construction of Imidazopyridinium Fluorescent Labels for Bioconjugation.Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Macrocyclic Peptides Containing an Imidazopyridinium (IPJournal of the American Chemical Society · 2026
    Article
  7. Review
  8. Article
  9. Macrocyclic Peptides Containing an Imidazopyridinium (IPbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bo LiDepartment of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.
Joshua ParkerDepartment of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.
Joel TongDepartment of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.
Thomas KodadekDepartment of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.ORCID 0000-0003-1930-4795

Funding

Novel platforms for the discovery of bioactive small moleculesR35GM151875 · NIGMS · UNIVERSITY OF FLORIDA · PI Thomas J. Kodadek · 2024 to 2026
$2.0M
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational ModificationsR21CA273954 · NCI · UNIVERSITY OF FLORIDA · PI KODADEK, THOMAS J. · 2022 to 2022
$497k
NCI NIH HHS R21 CA273954NIGMS NIH HHS R35 GM151875
6 · The paper itself

Abstract

Macrocyclic peptides (MPs) are a class of compounds that have been shown to be particularly well suited for engaging difficult protein targets. However, their utility is limited by their generally poor cell permeability and bioavailability. Here, we report an efficient solid-phase synthesis of novel MPs by trapping a reversible intramolecular imine linkage with a 2-formyl- or 2-keto-pyridine to create an imidazopyridinium (IP

Indexed as

ImidazolesCell Membrane PermeabilityMacrocyclic CompoundsMolecular StructurePeptides, CyclicPyridinesImidazolesimidazopyridineMacrocyclic CompoundsPeptides, CyclicPyridines

Identifiers

PMID38752889
PMCPMC11705912

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.